Concepedia

Nancy Alvandi

NA

9

Publications

225

Citations

9

H-Index

2018

Active since

Affiliations

Allergan (United States)(Current)

Nancy Alvandi is an author at Allergan (United States) specializing in medicine, dermatology, and antimicrobial drug discovery.

Top concepts

Publications per year

2018–2020

9

Publications

9

Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris

George G. Zhanel, Ian A. Critchley, Lynn-Yao Lin et al. · Antimicrobial Agents and Chemotherapy · 2018 · 72 citations · Full text

Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52-week open label REVEAL trial

Zoé Kececioglu Draelos, Michael H. Gold, Robert A. Weiss et al. · Journal of the American Academy of Dermatology · 2018 · 52 citations · Full text

Clean intermittent catheterization rates after initial and subsequent treatments with onabotulinumtoxinA for non-neurogenic overactive bladder in real-world clinical settings

Michael Kennelly, Lonny Green, Nancy Alvandi et al. · Current Medical Research and Opinion · 2018 · 19 citations

Oxymetazoline and Energy‐Based Therapy in Patients with Rosacea: Evaluation of the Safety and Tolerability in an Open‐Label, Interventional Study

Emil Tanghetti, David J. Goldberg, Jeffrey S. Dover et al. · Lasers in Surgery and Medicine · 2020 · 17 citations · Full text

Clinically Relevant Reduction in Persistent Facial Erythema of Rosacea on the First Day of Treatment With Oxymetazoline Cream 1.0.

Emil Tanghetti, Jeffrey S. Dover, David J. Goldberg et al. · PubMed · 2018 · 15 citations

Rows per page

1–5 of 9